Merck & Co. has speared an acquisition target, agreeing to pay $680 million for Harpoon Therapeutics and its pipeline of T-cell engagers. The deal will give Merck control of drug candidates that will ...
Medics were shocked to find that a fisherman had been struck with a harpoon — and not by accident. Sujit Klingtalay was out with friends fishing and drinking beers in the Nakhon Ratchasima province of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results